You appear to be offline. Some data may be unavailable until your connection is restored.

DVA

Stock

DaVita Inc

Create price alert
$174.07
-$9.43 (5.14%)
At close: Nov 12, 2026, 4:00 PM

Description

DaVita Inc. is a healthcare company that delivers kidney dialysis and related care services, operating outpatient dialysis centers, home‑based dialysis, hospital inpatient dialysis and associated laboratory and care‑management offerings. It focuses on patients with end‑stage renal disease and chronic kidney disease, providing both hemodialysis and peritoneal dialysis within an integrated kidney‑care model. The firm belongs to the healthcare sector, specifically the kidney‑care and dialysis industry. DaVita is one of the two largest dialysis providers in the United States, commanding roughly a third of the U.S. dialysis market and operating a nationwide network of more than 2,600 outpatient centers along with an international footprint. Its business model emphasizes scale, physician partnerships, and value‑based care contracts to support patient treatment continuity.

Quarterly Earnings

QuarterDateEPS
Q4 FY26Jan 25, 2027 (est.)—
Q3 FY26Oct 29, 2026$3.82
Q2 FY26Aug 4, 2026$4.02
Q1 FY26May 5, 2026$2.87
Q4 FY25Feb 2, 2026$3.40

Stay ahead of DVA earnings

Get reminders ahead of DVA's next earnings report, so you always know when results are coming.

Other Healthcare stocks in the S&P 500